Primarily, there are three uses for the prescription medication, Xeomin, which is applied by a muscle injection. Cervical dystonia (CD) causes an abnormal head position or neck pain in adults. Abnormal eyelid spasms may result from a Botox injection. Severe frown lines are considered unpleasant by some. These conditions can be treated with Xeomin.

Serious side effects that may be life threatening may be caused by Xeomin. Medical attention should be sought immediately if symptoms occur. They can happen hours or weeks following a Xeomin treatment.

Breathing, speaking, or swallowing difficulty is cause for concern. The muscles used for these functions become weak. People who need to use neck muscles to aid in breathing may be at a higher risk. The FDA has imposed the strictest mandate in its power for approved substances, like Xeomin. A boxed warning is carried on all botulinum products.

In 2011, the FDA approved the use of Xeomin for severe facial wrinkles. Prior to that time, it could only be used for blepharospasms or cervical dystonia in adults. The product is manufactured by Merz Pharmaceuticals.

The new approval puts the medication in a class with Disport, and Botox. Other alternatives to Botox are being studied at the present time, also. Xeomin injections have been used more than 84,000 times throughout the world. The US is not the first country to offer Xeomin as a cosmetic solution. Nineteen other countries allowed its use prior to US approval.

Xeomin is a neurotoxin similar to Disport and Botox. The differences are probably more significant to the injector or physician than to the consumer. Of the three, Xeomin is the only medication that does not require refrigeration. Distribution, therefore, may be simpler. There are no additives in Xeomin. It consists of type a botulinum toxin. This could prevent antibodies from developing against Xeomin. Antibodies develop as an attack response to foreign invasion. Those antibodies could prevent the desired effect.

It takes approximately a week for the full effects of Xeomin to be realized. Results remain for a period of three months up to six months. Botox produces comparable results. The products are not interchangeable.

Standard Xeomin treatments cost from $400 to $600. That is in line with the cost of Botox. It is perhaps a little cheaper. However, the recent approval of Xeomin keeps that price a little unstable. Price should be checked before agreeing to the procedure.